CLL Global Research Foundation

 

Upcoming Events
  • Home
  • CLL Information
    • Biology
    • Age & Symptoms
    • Diagnosis
    • Immunology
    • Prognostic Factors
    • Treatments
    • Familial CLL
    • Other
  • News & Views
    • Latest News
    • Upcoming Events
    • President’s Corner
    • Newsletters
    • Multimedia
  • Funded Research
    • Individual Grants
    • Alliance Grants
    • Research Success
    • Other Funding
  • Grant Applications
  • About
    • About Us
    • Mission & Objectives
    • Board of Directors
    • Scientific Advisory Board
  • Donate
  • Contact Us

Newsletters

Tidbits is a lighter take on the happenings in the CLL research community. Click below to catch up previous issues or to sign up to receive Tidbits.
tidbits

View the Tidbits Archive


 

Read CLL Research Momentum to stay informed about projects we are funding and progress made in the fight against CLL.
momentum
2022 Year in Review
Good News for CLL Patients
2022 MidYear Update
CLL Global Alliance Meeting
2021 Year in Review
Congratulations Dr. Wierda
2020 Year In Review
CLL the New Era
2020 MidYear Update
We Are Not Done yet!
2019 Year in Review
Celebrating Advances in CLL Research
2018 Year in Review
Celebrating Advances in CLL Research
2017 Year in Review
The Rocket has Launched
2016 Year in Review
Curing CLL – The Big Push
January 2016
CLL Global Alliance Meeting
2015 Year in Review
Looking Back, Moving Forward
December 2015
News from American Society of Hematology
November 2015
Research Update • Giving Opportunities
October 2015
Town Hall meeting on Octover 25, 2015 • Remembering Byron “Mack” Rankin, Jr. 
August – September 2015
CLL Global Alliance Meeting Highlights
July 2015
Global Grantee Highlight – Dr. Elizabeth Shpall, MD and Dr. Katy Rezvani, MD, PhD • Save the Date for Town Hall meeting
June 2015
Global Grantee Highlight – Dr. Deepah Sampath, PhD • New Targeted Combination Therapies • Town Meeting 
May 2015
Cancers Common in CLL Patients • Decade of Making a Difference
Issue 2 – 2013
A True Hero: Mack Rankin • Protect Yourself Against the Flu • Landscape of CLL • New Projects • Start Using Cure with CLL?
Issue 1 – 2013
Passion & Means • Q&A: Dr. Neil Kay • Green Tea Update • CLL Research Wish List • New Projects
Issue 2  2012
MD Anderson Moon Shot • Summer Alliance Meeting • Expanding Collaborations • Targeted Treatments • Letter Writing Campaign • Grant Project Updates
Issue 1 – 2012
Chronic versus acute • Immunotherapy • Q&A: Dr. Stephan Stilgenbauer • New projects • Partnership opportunities
Issue 2 – 2011
Significance of historical information • Chimeric Antigen Receptors (CARs) • Q&A: Dr. Laurence Cooper • Bruton’s tyrosine kinase • Partner Perspective: Will Newman
Issue 1 –  2011
Global collaborations • Alliance meeting • MicroRNAs • Q&A: Dr. George Calin • p53 • Stem cell transplant • Creative givingN
Holiday 2010
Philanthropy will cure CLL • Mouse models • Signal transduction inhibitors • CLL in the elderly • Patient symposium • Prognostic factors • Cord blood transplant
Summer 2010
State of CLL research • CLL Global’s history • Alliance meeting • Alliance collaborations • Researchers in the background • Projects reach clinic
Spring 2010
Genetics • Personalized therapy • Epstein-Barr virus • Clinical trial introduction • New projects
Fall 2009
Targeting ROR1 • CLL pathways • Relapsed CLL • Stem cell transplant introduction • Beyond FCR • Genetics • Skin cancer • TCL1
Summer 2009
Investing in CLL research • Genetics • FCR data • Microbead technology
Winter 2008
How will CLL be cured? • Q&A: Dr. Emil J Freireich • Alliance update • 8-chloro-adenosine • New drugs • Secondary cancers • Flu shots • Ripple effect of grants
Summer 2008
Alliance introduction • Targeting proteins • Cellular signals • Alliance meeting • Minimal residual disease • CLL immunity collaboration • Immune system education • Proactive patient
Fall 2007
CLL microenvironment • Cure CLL now • Stat-3 • Single nucleotide polymorphisms • TCL1 • Alemtuzumab • Heavy water
Spring 2007
Familial CLL • Prognostic factors • Educating T-cells • Mapping genes • Gene modification • ZAP-70 • CD38
Fall 2006
Gene therapy studies • Initial grants • Green tea • Glycolycin • 8-chloro-adenosine • Protein expression • Indolent or aggressive CLL

 

Donate to CLL
Join Our Mailing List

CLL: Where We Have Been and Looking to the Future

Renowned CLL experts Dr. Michael Keating and Dr. William Wierda talk with Patient Power Founder Andrew Schorr about the evolution of CLL care and the ways CLL Global Research Foundation is investing in the future.

Watch the interview


CLL GLOBAL RESEARCH FOUNDATION

P.O. Box 301402
Houston, TX 77230

MISSION STATEMENT

Our mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.

NEWSLETTER

Join Our Mailing List

Join Us on facebook

f_logo small

Copyright © 2023 CLL Global · Website designed by White Space Web Studio · Log in